Also participating in the study were Aviya Habshush Menachem, Dr. Natalia Davidzohn, Aviya Katz, Vladyslav Holiar, Neta Blumberger and Dr. Dotan Hoffman of Weizmann’s Immunology and Regenerative Biology Department; Dr. Noa Wigoda, Dr. Ron Rotkopf and Dr. Inna Goliand of Weizmann’s Life Sciences Core Facilities Department; Tzipi Braun from Sheba Medical Center, Tel Hashomer; Shira Leebhoff and Prof. Myriam Grunewald of the Hadassah Organoid Center, Jerusalem; Dr. Dayana Yahalomi, Dr. Meital Kupervaser and Dr. Yishai Levin of the Nancy and Stephen Grand Israel National Center for Personalized Medicine at the Weizmann Institute; and Dr. Tali Dadosh, Dr. Smadar Levin-Zaidman and Dr. Nili Dezorella of Weizmann’s Chemical Research Support Department.




